Literature DB >> 9109091

Molecular analysis of putative pneumococcal virulence proteins.

J C Paton1, A M Berry, R A Lock.   

Abstract

Although the polysaccharide capsule has been recognized as a sine qua non of virulence, recent attention has focused on the role of pneumococcal proteins in pathogenesis, particularly in view of their potential as vaccine antigens. The contribution of pneumolysin, two distinct neuraminidases, autolysin, hyaluronidase, and the 37 kDa pneumococcal surface adhesin A has been examined by specifically mutagenizing the respective genes in the pneumococcal chromosome and examining the impact on virulence in animal models. The vaccine potential of these proteins has also been assessed by immunization of mice with purified antigens, followed by challenge with virulent pneumococci.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9109091     DOI: 10.1089/mdr.1997.3.1

Source DB:  PubMed          Journal:  Microb Drug Resist        ISSN: 1076-6294            Impact factor:   3.431


  20 in total

Review 1.  Streptococcus pneumoniae.

Authors:  J R Catterall
Journal:  Thorax       Date:  1999-10       Impact factor: 9.139

2.  Virulence of Streptococcus pneumoniae: PsaA mutants are hypersensitive to oxidative stress.

Authors:  Hsing-Ju Tseng; Alastair G McEwan; James C Paton; Michael P Jennings
Journal:  Infect Immun       Date:  2002-03       Impact factor: 3.441

3.  The autolysin-encoding gene (lytA) of Streptococcus pneumoniae displays restricted allelic variation despite localized recombination events with genes of pneumococcal bacteriophage encoding cell wall lytic enzymes.

Authors:  A M Whatmore; C G Dowson
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

4.  Resistance to both complement activation and phagocytosis in type 3 pneumococci is mediated by the binding of complement regulatory protein factor H.

Authors:  C Neeleman; S P Geelen; P C Aerts; M R Daha; T E Mollnes; J J Roord; G Posthuma; H van Dijk; A Fleer
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

5.  Mosaic genes and mosaic chromosomes: intra- and interspecies genomic variation of Streptococcus pneumoniae.

Authors:  R Hakenbeck; N Balmelle; B Weber; C Gardès; W Keck; A de Saizieu
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

6.  Detection of 23 immunogenic pneumococcal proteins using convalescent-phase serum.

Authors:  G Zysk; R J Bongaerts; E ten Thoren; G Bethe; R Hakenbeck; H P Heinz
Journal:  Infect Immun       Date:  2000-06       Impact factor: 3.441

7.  Pneumococcal surface protein A is expressed in vivo, and antibodies to PspA are effective for therapy in a murine model of pneumococcal sepsis.

Authors:  E Swiatlo; J King; G S Nabors; B Mathews; D E Briles
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

Review 8.  Pneumococcal vaccination and revaccination of older adults.

Authors:  Andrew S Artz; William B Ershler; Dan L Longo
Journal:  Clin Microbiol Rev       Date:  2003-04       Impact factor: 26.132

9.  Pneumococcal surface protein A contributes to secondary Streptococcus pneumoniae infection after influenza virus infection.

Authors:  Quinton O King; Benfang Lei; Allen G Harmsen
Journal:  J Infect Dis       Date:  2009-08-15       Impact factor: 5.226

10.  The human polymeric immunoglobulin receptor facilitates invasion of epithelial cells by Streptococcus pneumoniae in a strain-specific and cell type-specific manner.

Authors:  Sean C Brock; Patricia A McGraw; Peter F Wright; James E Crowe
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.